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ARTICLE
Fecal microbiota transplant rescues mice from
human pathogen mediated sepsis by restoring
systemic immunity
Sangman M. Kim 1,2,3,12, Jennifer R. DeFazio4,5,12, Sanjiv K. Hyoju4, Kishan Sangani1,2, Robert Keskey1,4,
Monika A. Krezalek4, Nikolai N. Khodarev6, Naseer Sangwan4,7, Scott Christley4, Katharine G. Harris2,
Ankit Malik1,2, Alexander Zaborin4, Romain Bouziat1,2, Diana R. Ranoa6, Mara Wiegerinck 4, Jordan D. Ernest2,
Baddr A. Shakhsheer4, Irma D. Fleming 4, Ralph R. Weichselbaum6, Dionysios A. Antonopoulos2,7,
Jack A. Gilbert 4,7, Luis B. Barreiro2,8,9, Olga Zaborina4,13, Bana Jabri1,2,10,11,13✉ & John C. Alverdy4,13✉
Death due to sepsis remains a persistent threat to critically ill patients confined to the
intensive care unit and is characterized by colonization with multi-drug-resistant healthcare-
associated pathogens. Here we report that sepsis in mice caused by a defined four-member
pathogen community isolated from a patient with lethal sepsis is associated with the sys-
temic suppression of key elements of the host transcriptome required for pathogen clearance
and decreased butyrate expression. More specifically, these pathogens directly suppress
interferon regulatory factor 3. Fecal microbiota transplant (FMT) reverses the course of
otherwise lethal sepsis by enhancing pathogen clearance via the restoration of host immunity
in an interferon regulatory factor 3-dependent manner. This protective effect is linked to the
expansion of butyrate-producing Bacteroidetes. Taken together these results suggest that
fecal microbiota transplantation may be a treatment option in sepsis associated with
immunosuppression.
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S ince the discovery of penicillin in 1928, antibiotics havesaved millions of lives, however, their promiscuous use inmedicine and agriculture has borne witness to the emer-
gence of multidrug resistant (MDR) pathogens which has become
one of the most pressing issues in public health today1,2. The
most common cause of death in modern intensive care units is
“late-onset sepsis,” a disorder characterized by colonization with
highly virulent MDR pathogens3. Colonization of critically ill
patients with MDR pathogens is likely a result of the unusual
selective pressures to which these patients and their microbiomes
are exposed, including life support measures, prolonged antibiotic
use, polypharmacy, and artificial feeding. These well-intentioned
interventions can result in collapse of the microbiome, the dys-
regulation of which is increasingly being demonstrated to have a
major adverse effect on the immune system. Here we demonstrate
that a fecal microbiota transplant (FMT) can rescue mice from
lethal sepsis due to a defined four-member pathogen community
(PC) isolated from a critically ill patient by reversing the
immunosuppressive effect of this PC.
Results
FMT rescues mice from gut-derived sepsis. We infected mice
with a PC isolated from the stool of a surgical patient who died of
late-onset sepsis, consisting of three species of bacteria (tetra-
cycline resistant Enterococcus faecalis, MDR Klebsiella oxytoca,
and MDR Serratia marcescens) and one species of yeast (Candida
albicans)4 (Supplementary Table 1). With advances in sequen-
cing, it is now known that the gut is the primary site of coloni-
zation and emergence of the “antibiotic resistome” consisting of
MDR pathogens and is a major source of lethal systemic infec-
tions5–7. Therefore, we first inoculated this four-member PC into
the gut using a model that exposes the PC to the selective pres-
sures of surgical injury and its treatment. In this model, mice
were subjected to 30% hepatectomy, with preoperative food-
deprivation and prophylactic antibiotic administration4,8,9
(Fig. 1a). In accordance with previous studies9, by postoperative
day 1 (POD1) the majority of mice had positive blood, liver, lung,
and spleen cultures (Fig. 1b) with clinical signs of sepsis (lethargy,
ruffled fur, and chromodacryorrhea) and died by POD2 (Surgery
+ PC) (Fig. 1c and Supplementary Table 2).
Given that FMT has been shown to drive the competitive
exclusion of pathobiota among the indigenous intestinal micro-
biota10–12, we applied FMT to our model to determine its ability
to rescue mice that would be predicted to develop lethal sepsis.
FMT prepared from cecal contents of healthy littermates was
administered via enema on 2 consecutive days (Fig. 1a).
Remarkably, administration of FMT led to a greater than 70%
increase in survival, compared with no improvement in survival
when mice received an autoclaved FMT (AC-FMT) (Fig. 1c). The
finding that AC-FMT-treated mice had the same clinical
phenotype and survival outcome as untreated septic mice
indicated that live microbiota needs to be transplanted, and
therefore for the remainder of this study, we used AC-FMT
treatment as our control for live FMT. Strikingly, FMT treatment
resulted in an overall decrease in systemic PC burden by POD2,
with significantly lower CFUs of S. marcescens in the blood and C.
albicans in the liver and spleen compared with AC-FMT-treated
mice (Mann–Whitney test, P < 0.05) (Fig. 1d). Taken together,
these results demonstrate that administration of a live, but not an
autoclaved FMT, reduces systemic pathogen burden and
dramatically increases survival in mice with lethal gut-derived
sepsis.
In order to gain further insight into the mechanism of FMT-
mediated protection and its ability to reduce systemic PC burden
in this model, we performed whole-genome microarray analysis
of gene expression in the cecum, liver, and spleen on POD2, the
time point where we observed FMT-driven reduction of systemic
pathogen burden (Fig. 1d). We looked at genes that were
coordinately regulated across all three organs and observed
significant changes in gene expression in both FMT and AC-
FMT-treated groups compared with non-manipulated control
mice (referred to as “Untreated” hereafter) (Fig. 1e and
Supplementary Data 1). However, the number of differently
expressed genes was approximately tenfold less (349 vs. 3242 at
an FDR ≤ 0.01) in FMT-treated mice as compared with AC-FMT-
treated septic mice (Fig. 1e and Supplementary Data 1). Among
differently expressed genes, the magnitude of the gene expression
changes was also consistently lower in FMT-treated mice
(Mann–Whitney test, P < 1 × 10−15) (Fig. 1f), suggesting that
FMT treatment restores a dysregulated transcriptional program
associated with PC dissemination. Pathway and database analysis
of the PC-induced dysregulated transcriptional program (Supple-
mentary Fig. 1, Supplementary Data 1, and 2) suggested that the
systemic dissemination of pathogens was accompanied by a
coordinated abrogation of signaling downstream of pattern
recognition receptors (PRRs), a pathway that is commonly
targeted by microbial pathogens and required for their clear-
ance13–17. Both interferon regulatory factor 3 (IRF3) and the
nuclear factor-kappa B (NF-κB) signaling pathways were
dysregulated in AC-FMT-treated septic mice, while FMT
treatment restored these pathways back to homeostatic levels in
three different organs, two of which are remote from the gut
(Supplementary Fig. 1a, Supplementary Data 1, and 2).
Intriguingly, although the translocation of the PC began before
treatment with FMT on POD1 (Fig. 1b), FMT was still able to
drive a reduction in PC burden in systemic organs (Fig. 1d)
suggesting two possible, but non-mutually exclusive mechanisms.
First, FMT could promote colonization resistance and the
competitive exclusion of the PC within the gut environment in
a manner similar to the mechanism by which FMT clears
recurrent Clostridium difficile infection10–12 thereby preventing
further translocation and facilitating systemic clearance of the PC.
Indeed, temporal sequencing of 16S rRNA of cecal contents
demonstrated that FMT, but not AC-FMT treatment, restored
intestinal microbial diversity (Supplementary Fig. 2a–d and
Supplementary Table 3) in association with a marked reduction
of all three inoculated bacterial pathogens over time (Supple-
mentary Fig. 2e–g). By POD7, the inoculated pathogens were
completely absent from the ceca of FMT-treated mice (Supple-
mentary Fig. 2e–g). A second mechanism might involve the
ability of FMT to drive a recovery-directed immune response at
the systemic level, as suggested by our transcriptional analysis
(Fig. 1e,f, Supplementary Fig. 1, Supplementary Data 1 and 2),
thereby enhancing bacterial clearance in peripheral organs and
preventing the progression to lethal infection.
FMT drives the clearance of systemically disseminated PC. To
test the latter possibility that FMT drives a systemic recovery-
directed immune response in the above model, we injected the PC
directly into the peritoneal cavity (intraperitoneal-i.p.) which
caused immediate systemic dissemination of pathogens; in this
series of experiments there was no fasting, surgery, or antibiotics
(IP model) (Fig. 2a). Therefore, this model separated the FMT
treatment and PC inoculation into physically isolated compart-
ments (i.e., FMT via enema, PC via i.p. injection) thus allowing
assessment of the direct role of FMT on systemic PC clearance. In
this model, PC inoculation resulted in immediate systemic sepsis
and death in more than 60% of mice in less than 72 h (PC)
(Fig. 2b). To assess the ability of an FMT enema to reverse the
mortality from i.p. administered PC, mice were treated with
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Fig. 1 FMT rescues mice from lethal infection due to a four-member pathogen community isolated from a patient with lethal sepsis. a–f To mimic the
development of sepsis following major surgery, C57BL/6 mice were starved and received a single-intramuscular injection of cefoxitin, after which they
were opened, subjected to 30% hepatectomy, and inoculated with the PC directly into their cecum. To test the protective effects of FMT, 24 h (POD1) and
48 h (POD2) after surgery, FMT or AC-FMT was administered via enema. a Sketch and timeline of the gut-derived sepsis model. b The percentage of mice
with microbes present on POD1 in the indicated sites was measured by homogenizing organs and culturing them on TSB agar plates. The percentage of
mice that had positive cultures out of all of the mice assessed are graphed for the groups indicated (n= 5, 7, and 8 mice for untreated, POD1 blood and
spleen, and POD1 liver and lung, respectively). c Kaplan–Meier survival curves for indicated groups. “Surgery” are control mice that had starvation,
antibiotics, and surgery without pathogen inoculation (n= 15 mice/group; Log-rank (Mantel–Cox) test; P < 0.0001 between Surgery+ PC/Surgery+ PC+
FMT, P= 0.9554 between Surgery+ PC/Surgery+ PC+AC-FMT, P < 0.0001 between Surgery+ PC+ FMT/Surgery+ PC+AC-FMT). d Quantitative
culture results of indicated sites comparing the PC burden of Surgery+ PC+ FMT and Surgery+ PC+AC-FMT-treated mice at POD2. Each of the four PC
members were assessed separately using selective culture plates. On radar plot, each dot along the axes represents the CFU/mL of blood or CFU/mg of
liver and spleen of one mouse, the further the distance from the center of the plot, the higher the pathogen burden. The third and first quartiles and the
median are indicated with the edges of the colored boxes and the thick black line respectively (n= 5 mice/group; Mann–Whitney test; PC burden
significantly different between AC-FMT/FMT in the blood [SM*], liver [CA*], spleen [CA*], *P≤ 0.05). e, f The cecum, liver, and spleen of Surgery+ PC
+ FMT or Surgery+ PC+AC-FMT-treated mice was harvested on POD2, mRNA was extracted from whole tissues, and gene expression was measured
using whole-genome microarray. Gene expression was compared against the baseline of untreated control mice (denoted “Untreated”; n= 3 mice/group).
e Venn diagram showing the number of genes differently expressed (FDR≤ 0.01) across all organs on POD2 in FMT and AC-FMT-treated mice.
f Distribution of the absolute log2-fold change in FMT and AC-FMT-treated mice on POD2 among genes differently expressed in either condition
(Mann–Whitney test; P < 1 × 10−15).
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either FMT or AC-FMT via enema two times; at the time of PC
inoculation and 14 h post inoculation (Fig. 2a). Remarkably,
administration of FMT resulted in a greater than 40% increase in
survival in the i.p. injected mice compared with no improvement
in survival in AC-FMT-treated mice (Fig. 2b). Treatment with
FMT resulted in significant clearance of all the PC members from
peripheral organs compared with AC-FMT-treated mice (Fig. 2c).
Taken together these data suggest that FMT can modulate sys-
temic host physiology in a way that drives pathogen clearance at
remote sites.
The rescue effect of FMT occurs in an IRF3-dependent man-
ner. Microbial pathogens are sensed by the wide array of PRRs
that are found on the surface and inside of cells that lead to the
activation of the NF-κB and/or IRF3 signaling pathways. In the
case of Gram-negative bacteria, recognition by TLR4 causes the
concomitant activation of both pathways18,19. Many successful
pathogens have evolved methods to avoid detection by these
PRRs through a variety of molecular mechanisms13–17, including
the transcriptional modulation of host signaling pathways17,20,21.
Consistent with our findings in the gut-derived lethal infection
model (Fig. 3a, Supplementary Fig. 1, Supplementary Data 1 and
2), i.p. injection of the PC resulted in downregulation of IRF3 and
the upregulation of NF-kB Inhibitor Alpha (NFKBIA), NF-kB
Inhibitor Beta (NFKBIB), and TNF Alpha Induced Protein 3
(TNFAIP3), known NF-κB pathway inhibitors22,23, in the cecum,
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Fig. 2 FMT drives the clearance of systemically disseminated pathogens. a–c In order to cause immediate systemic dissemination, the PC was injected
directly into the peritoneum (IP) of mice. In the IP model, mice were not subjected to starvation, antibiotic treatment, or hepatectomy. To test the
protective effects of FMT in this model, immediately upon injection of PC and then once more 14 h post injection, FMT or an AC-FMT was administered via
enema. a Timeline of the IP sepsis model. b Kaplan–Meier survival curves (n= 21, 26, and 25 for PC, PC+ FMT, and PC+AC-FMT-treated mice,
respectively; Log-rank (Mantel–Cox) test; P= 0.001 between PC/PC+ FMT, P= 0.4905 between PC/PC+AC-FMT, P < 0.0001 between PC+ FMT/PC
+AC-FMT). c Quantitative culture results of indicated sites comparing the PC burden of PC, PC+ FMT, and PC+AC-FMT mice ~20 h post injection of PC.
On radar plot, each dot along the axes represents the CFU/mL of blood and peritoneal fluid or CFU/mg of liver and spleen of one mouse, the further the
distance from the center of the plot, the higher the pathogen burden. The third and first quartiles and the median are indicated with the edges of the
colored boxes and the thick black line respectively (n= 5 mice/group); Kruskal–Wallis test/Dunn’s multiple comparisons test; PC burden significantly
different between PC/PC+ FMT in the blood [SM*], liver [KO**, SM*], peritoneum [CA*, KO*, SM*], and spleen [CA**, KO*]. PC burden significantly
different between PC+AC-FMT/PC+ FMT in the blood [EF**, KO*], liver [CA**, EF**, SM*], peritoneum [CA**, EF**, KO*], and spleen [EF*, KO*, SM*].
No significant differences between PC/PC+AC-FMT. *P≤ 0.05, **P≤ 0.01.
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liver, and spleen, 20 h post PC injection in AC-FMT mice
(Fig. 3b, Supplementary Fig. 3a, and Supplementary Table 4).
Intriguingly, we observed the same gene expression changes
in vitro when we cultured mouse embryonic fibroblasts (MEFs)
with individual members of the PC that were either live (Sup-
plementary Fig. 3b) or lysed and filtered (Fig. 3c and Supple-
mentary Fig. 3c), with specific members driving more dramatic
levels of transcriptional modulation. In particular, both live S.
marcescens and its lysates drove the most dramatic down-
regulation of IRF3, while live K. oxytoca drove the most dramatic
upregulation of NF-κB inhibitors (Fig. 3c and Supplementary
Fig. 3b, c). Bacterial lysates prepared from cecal contents of
untreated mice (Microbiota) did not lead to a reduction in IRF3,
although it did upregulate NFKBIA and TNFAIP3 at the highest
dose tested (Fig. 3c and Supplementary Fig. 3c). Taken together,
these results suggest that individual members of the PC have both
distinct and complementary abilities to directly modulate NF-κB
and IRF3 signaling with the net result being blockade of NF-κB
and IRF3 signaling in both models of infection. Importantly, in
both models, treatment with FMT restored these signaling
pathways back to homeostatic levels (Supplementary Fig. 1a,
Fig. 3b, and Supplementary Fig. 3a) suggesting that FMT may
protect these mice through restoration of immune homeostasis in
the face of direct immune subversion by the PC.
IRF3 is a transcription factor that drives the production of type
I interferons and inflammatory cytokines18,19, and intact
IRF3 signaling is required for immunity against certain Gram-
positive and Gram-negative bacteria24–26. The observation that
MyD88-deficient patients are resistant to most common bacterial
infections27 further suggests that the IRF3 pathway, which is not
dependent on MyD88, may be involved in protective immunity.
Importantly, unlike mice that lack NF-κB signaling compo-
nents28, IRF3-deficient mice do not display overt developmental
or immunological defects at steady-state conditions29. Finally, in
both the gut-derived and IP models of sepsis herein described,
IRF3 was observed to be downregulated with the progression of
sepsis across organs, and treatment with FMT restored IRF3 to
normal levels (Supplementary Fig. 1a and Fig. 3b). Therefore, we
hypothesized that IRF3 may be required for FMT-mediated
protection. To test this, we performed reiterative experiments in
the IP model with IRF3-sufficient and IRF3-deficient littermates.
In accordance with IRF3 playing a role in protective immunity
against the PC, IRF3-deficient mice displayed increased mortality
upon PC infection as compared with IRF3-sufficient littermates,
with mice heterozygous for IRF3 having intermediate survival
(Supplementary Fig. 4). Importantly, IRF3-deficient mice did not
demonstrate an increase in survival upon treatment with FMT
(Fig. 3d) and FMT-treated IRF3-deficient mice had significantly
higher PC burden in peripheral sites when compared with FMT-
treated IRF3-sufficient littermates (Fig. 3e) indicating that FMT
required intact IRF3 to clear the PC and rescue mice from
pathogen-induced lethal sepsis. These results are in contrast to
findings reported with the cecal puncture and ligation model of
sepsis in which commensal microbiota and a grossly ischemic
cecum drive the process of lethal sepsis. In the cecal ligation
model, IRF3-deficiency has been shown to be protective30,
potentially indicating the difference between sepsis driven by
mouse commensal microbiota versus sepsis caused by a defined
community of sepsis-associated human pathogens.
PC infection drives a reduction in fecal butyrate levels. We next
sought to clarify how FMT might protect mice in the IP model,
given that, unlike in the gut-derived sepsis model, it is presumed
that IP injected mice will have maintained an intact microbiota at
the time of FMT treatment. However, others have shown that any
sudden physiologic insult can rapidly (within 6 h) deplete
microbiome composition and function31. I.p. injected mice
demonstrated no significant change in either total bacterial load
(Supplementary Fig. 5a) or microbiota composition (Supple-
mentary Fig. 5b, c) at 14 h post PC injection. This lack of com-
positional change by 16S rRNA analysis was also observed in
mice that received AC-FMT or FMT treatment (Supplementary
Fig. 5a–c). This finding further indicates that FMT in this model
does not mediate survival by promoting colonization resistance
and the competitive exclusion of the PC.
Healthy microbiota can affect systemic immune homeostasis
and enhance pathogen clearance via the production of metabo-
lites such as short chain fatty acids (SCFA)32–34. To further define
through which mechanisms FMT may mediate its effect, we
investigated whether there were any alterations in SCFA
expression in PC injected septic mice. Strikingly, cecal butyrate
levels, but not acetate and propionate levels (Supplementary
Fig. 6a, b), were significantly diminished in mice following i.p. PC
injection (Fig. 4a). Consistent with this observation, selective
downmodulation of butyrate production has been reported in
other models of inflammation35. These findings led us to
investigate whether reduction and restoration in butyrate levels
could be linked to changes in specific bacterial populations
(OTUs).
Interestingly, in PC infected mice, a significant reduction in the
abundance of five OTUs from the phylum Firmicutes are
members of the Clostridium cluster XIVa (based on RDP
SeqMatch searches36; Supplementary Fig. 6c), which is a cluster
that contains many taxa that are known butyrate producers37.
Butyrate kinase (buk) and butyrate transferase (but) are the
enzymes catalyzing the last step in butyrate production by
bacteria37. More specific analysis, however, found only one of the
OTUs proportionally decreased in PC infected mice to match
organisms containing the buk or but genes in the RDP FunGene
database36. Hence, it is possible that in addition to changes in
OTUs, there is a defect in the transcription of butyrate processing
enzymes, and/or an increased uptake of butyrate that contribute
to the observed decreased expression in butyrate. Whatever
caused the decrease in butyrate, FMT treatment of septic mice led
to a restoration of butyrate levels (Fig. 4a) that was associated
with a significant increase in OTUs that belonged to the phylum
Bacteroidetes, including a large number of S24-7 family members.
Based on RDP FunGene searches most of these OTUs have buk
and/or but (Fig. 4b). Although there was some overlap between
untreated mice and septic mice receiving FMT (Supplementary
Fig. 6d and Supplementary Data 3), the OTUs from Bacteroidetes
are specifically enriched in PC+ FMT mice (Supplementary
Fig. 6d). There are indications that members of Bacteroidetes
actively alter the gut environment to their benefit38 and are more
resilient colonizers than other phyla in the presence of acute
inflammation39. The rapid colonization of septic mice by “non-
traditional” butyrate-producing members of Bacteroidetes may
hence account for the restoration of butyrate levels in FMT-
treated mice.
Butyrate and HDACi normalize IRF3 levels in vitro. Given that
butyrate has histone deacetylase inhibitory (HDACi) activity that
can positively or negatively modulate transcription, we hypo-
thesized that FMT may mediate its beneficial effects via the
HDACi properties of butyrate. To test this hypothesis, we
determined whether butyrate could restore normal levels of IRF3
in vitro. When MEFs were treated with an equal concentration of
lysates from all four members of the PC, IRF3 transcript levels
were reduced to ~50%; however, culturing these cells in
the presence of butyrate led to a restoration of IRF3, in a
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dose-dependent manner (Fig. 4c). The restoration of IRF3 tran-
script levels by butyrate was dependent on the HDACi activity of
butyrate, and not on the effect of butyrate to signal through G-
protein coupled receptor 109A (GPR109a), as valproate (HDAC
Class I and IIa inhibitor) but not niacin (GPR109a agonist)32 was
able to restore IRF3 transcript levels in vitro (Fig. 4c). The SCFA
propionate is also known to have HDACi activity, while acetate
does not32, and thus propionate, but not acetate, was also able to
restore IRF3 (Fig. 4c). This is in line with previous studies that
have demonstrated a protective effect of both butyrate and
HDACi in animal models of sepsis40–44. We cannot eliminate
that in addition to restoring IRF3 levels, the presence of higher
levels of butyrate may also have a direct cytotoxic effect on
PC45,46. Furthermore, metabolites other than butyrate may con-
tribute to the clearance of PC in vivo47. Taken together, these data
suggest that critical illness itself may result in the depletion of
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containing filtered lysates made from cultured individual PC members, or from cecal contents of untreated mice at the indicated concentrations. MEF RNA
was isolated and IRF3 expression was measured by qPCR. (Fold change compared with the baseline of untreated MEF IRF3 relative expression [highlighted
with the dotted line at y= 1] shown; 3 independent experiments; n≥ 3 for all conditions; mean+ SD). d, e To assess the requirement for IRF3 in FMT-
mediated protection, IRF3+/+ and IRF3−/− littermates were injected i.p. with PC and treated with FMT or AC-FMT as before. d Kaplan–Meier survival
curves for genotypes and treatments indicated (n= 10, 7, 13, and 11 for IRF3+/+ mice with PC+ FMT, IRF3+/+ mice with PC+AC-FMT, IRF3−/− mice
with PC+ FMT, and IRF3−/− mice with PC+AC-FMT, respectively; Log-rank (Mantel–Cox) test; P= 0.0469 between IRF3+/+ PC+ FMT/IRF3+/+ PC+
AC-FMT, P= 0.5440 between IRF3−/− PC+ FMT/IRF3−/− PC+AC-FMT). e Quantitative culture results of indicated sites comparing the PC burden of
PC+ FMT-treated IRF3+/+ and IRF3−/− mice ~20 h post injection of PC. On radar plot, each dot along the axes represents the CFU/mL of blood and
peritoneal fluid or CFU/mg of liver and spleen of one mouse, the further the distance from the center of the plot, the higher the pathogen burden. The third
and first quartiles and the median are indicated with the edges of the colored boxes and the thick black line respectively (n= 5 mice/group; Mann–Whitney
test; PC burden significantly different between IRF3+/+ PC+ FMT/IRF3−/− PC+ FMT in the blood [EF*, SM*], liver [EF*, KO*, SM**], peritoneum [CA*,
KO*, SM*], and spleen [EF*, KO*]. *P≤ 0.05, **P≤ 0.01).
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intestinal butyrate. FMT, by providing OTUs such as Bacter-
oidetes, that can expand under inflammatory conditions and
produce butyrate, is able to protect against systemic PC infection.
Discussion
Here we present evidence that a PC expressing varying degrees of
antibiotic resistance isolated from the stool of a terminally septic
patient dysregulates, in a concerted manner, the transcriptional
program associated with host defenses against infections. By
blocking key parts of both the NF-κB and IRF3 signaling path-
ways, these pathogens prevent the host from mounting a pro-
tective immune response, which likely accounts for the high
systemic pathogen burden, host deterioration, and death seen in
this model. Unexpectedly, we found that FMT was able to counter
the immunosuppressive effects of these pathogens in part through
its ability to restore normal levels of butyrate. The ability of FMT
to provide protection in the IP model of lethal infection indicates
that FMT can act systemically, beyond its local effect on the
gastrointestinal microbiota or pathobiota, and restore protective
immunity against highly virulent and MDR pathogens. Under-
standing how FMT drives a recovery-directed immune response
at the systemic level may have important implications for the
management of critically ill patients who are regularly treated
with antibiotics and colonized by healthcare-associated patho-
gens. Given that the pathogen communities that colonize criti-
cally ill patients each carry their own unique life histories, results
from this study underscore the importance of humanizing the
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mouse gut with clinically relevant human pathogens when
assessing the immune response. The immunosuppressive nature
of the human PC herein described may explain, in part, why
mouse models of endotoxin administration or sepsis due to
rodent flora have failed to translate into effective therapies in
clinical trials48,49. Whether the current approach will be useful in
the design of future human trials will require further study.
Methods
Mice. Seven-to-nine-week-old-male C57BL/6 mice weighing 18–22 g were used for
experiments. WT C57BL/6 were purchased from Charles River Laboratories.
IRF3−/− mice on a C57BL/6 background were kindly provided by Dr Tatyana V.
Golovkina (University of Chicago) and mice used in comparative studies were the
progeny of IRF3+/− mice resulting in IRF3+/+ and IRF3−/− littermates. IRF3+/+
and IRF3−/− littermates were cohoused until the day of the experiment to prevent
microbiome related differences between genotypes from affecting results.
PC preparation. The PC consisted of four members including C. albicans, E.
faecalis, multidrug-resistant K. oxytoca, and multidrug-resistant S. marcescens and
was isolated from the stool of a critically ill patient (ICU1-2) who was exposed to
numerous antibiotics during the course of their sepsis4. The individual pathogens
were plated on TSB agar from individual frozen stocks and grown overnight at 37 °
C. Colonies were suspended in liquid TSB medium, subgrown for 1 h and then
adjusted to an optical density measured at wavelength of 600 nm (OD600) of 0.2.
All four microbe species were then combined together in equal volumes. The
microbial suspension was centrifuged at 6000 rpm for 10 min, the excess TSB
removed and the remaining pellet was resuspended in the same volume of 10%
glycerol. The resulting microbial suspension was administered in the two sepsis
mouse models as described below.
Gut-derived sepsis mouse model. All experiments were approved by the Insti-
tutional Animal Care and Use Committee at the University of Chicago (IACUC
protocol 71744). Mice were routinely fed tap water and Harland Teklad feed
(Madison, WI) under 12-h light/dark cycles and were allowed to acclimate for at
least 48 h before surgery. In order to mimic preoperative surgical conditions, mice
were exposed to food restriction and prophylactic antibiotics. Approximately 16 h
prior to surgery, mice were moved to wire floor cages to prevent coprophagy. Food
was removed, and mice were allowed only tap water ad libitum. Each mouse
received an intramuscular cefoxitin injection 30 min prior to the incision at a
concentration of 25 mg/kg into the left thigh. Mice were then subjected to a midline
laparotomy, 30% hepatectomy of the left lateral lobe of the liver and a direct cecal
inoculation of PC (200 µL of PC suspension prepared as described above). On the
day of surgery, a fresh FMT was prepared by harvesting the cecal contents of
normal healthy mice. Cecal contents were then suspended in sterile 10% glycerol at
a concentration of 50 mg/mL. An aliquot of the cecal contents was autoclaved and
resuspended in sterile 10% glycerol to a final concentration of 50 mg/ml to create
the autoclaved control (AC-FMT). On postoperative days one and two (POD1 and
POD2), randomly selected group of mice were given either 1 ml of FMT or AC-
FMT via rectal enema using a blunt vein irrigation cannula (Shiley/Pfizer). Chow
was restored to the cages on POD2, ~45 h after the operation. Survival and health
status were monitored and documented for 7 days using the clinical scoring system
shown in Supplementary Table 2 (after 7 days, mice that survive until this point,
regardless of treatment group return to full health and survive indefinitely). All
mice that were moribund were sacrificed and considered to be a mortality.
Nonquantitative culture of PC. The blood, liver, lung, and spleen of mice were
harvested on POD1 to determine the percentage of mice that had microbes present in
these compartments. Blood was collected via direct cardiac puncture, mixed with
glycerol to a final concentration of 10%, and stored at−80 °C. Ten milligrams of liver,
lung, and spleen were homogenized in 500 µl of 10% glycerol and stored at −80 °C.
Each sample was serially diluted and plated on TSB agar plates. All the plates were
incubated in 37 °C incubator for 24 h and then assessed for the presence of colonies.
Quantitative culture of PC. The blood, spleen and liver of mice were assessed for
colonization with PC species using selective plates: for C. albicans, CHROMagar
Candida plates (BBL); for K. oxytoca, MacConkey supplemented with cipro-
floxacin, 10 µg/ml; for S. marcescens, MacConkey supplemented with imipenem,
1 µg/ml; and for E. faecalis, Enterococcal agar plates (BBL) supplemented with
tetracycline, 100 µg/ml. The bacterial plates supplemented with antibiotics were
chosen based on their antibiotic resistance4 (Supplementary Table 1), and the
selectivity was verified by plating intestinal content of untreated mice with no
growth on the plates. CHROMagar Candida plates select for C. albicans seen as
blue colonies. Enterococcal agar plates select for Enterococcus seen as black colo-
nies. Blood, liver, and spleen were collected as before and stored at −80 °C. Peri-
toneal fluid was collected by 1 mL syringe and stored at −80 °C. Each sample was
serially diluted, and 50 µl of each dilution was plated on above mentioned four
selective plates. All the plates were incubated in 37 °C incubator for 24 h. CFU
counts were normalized to tissue weight for spleen and liver and volume for blood
and peritoneal fluid.
Mouse genome transcription analysis. As indicated in the original model
description, mice underwent the full protocol to allow for the development of gut-
derived sepsis (i.e., intestinal inoculation of the PC and surgical hepatectomy) and
were then treated with either a live FMT or AC-FMT (n= 3/group).
We performed gene expression analysis on POD2, because this was the time
point where we observed FMT-driven reduction of systemic pathogen burden. In
accordance with this reduction in systemic pathogen burden, the FMT-treated mice
had a clinical score of 1, while the AC-FMT-treated mice had a clinical score of 4 at
the time of sampling (scoring system described in Supplementary Table 2). The
cecum, left lobe of the liver, and spleen were resected and stored in RNA later
(Qiagen). Tissue was homogenized using Tissue-Tearor (Biospec Products) and
RNA extraction was performed using the RNeasy Plus Mini Kit (Qiagen) according
to the manufacturer’s instructions. Whole-genome transcriptional profiling was
performed using Illumina MouseRef-8 v2 arrays (Illumina) by the Functional
Genomics Facility of the University of Chicago.
Low-level microarray analyses were performed in R, using the Bioconductor
software package lumi50. We first applied a variance stabilizing transformation to
all arrays51 and then quantile normalized the data. After normalization, we
removed probes with intensities indistinguishable from background noise (as
measured by the negative controls present on each array). After these preprocessing
steps, data from 13,312 genes were available for differential expression analysis.
To identify genes whose expression levels were altered at POD2 after AC-FMT
or FMT treatment (as compared with untreated control mice), we used a linear
modeling-based approach. Specifically, we used the Bioconductor limma package52
to fit, for each gene, a linear model with individual treatment (i.e., AC-FMT or
FMT) and tissue as fixed effects. To identify changes in gene expression within each
tissue we ran a nested linear model where treatment was nested within tissue type.
Fig. 4 Pathogen infection drives butyrate deficiency and butyrate can restore IRF3 in vitro. aMice were injected IP with PC and treated with FMT or AC-
FMT as before. Cecal contents were collected ~20 h post injection of PC and butyrate levels were measured by GC–MS. (One-way ANOVA/Tukey’s
multiple comparison, *P≤ 0.05, **P≤ 0.01). b Analysis of the OTUs found in the datasets reveals that FMT increases the presence and abundance of
butyrate-producing bacteria. Changes in specific OTUs between mice treated with or without FMT were detected using the R packages phyloseq and
DESeq262,63. The figure depicts significant log2-fold changes based on an FDR (Benjamini–Hochberg) significance threshold of 0.01 in the relative
abundance of specific OTUs between PC and PC+ FMT mice as heatmaps. Representative sequences for each of these OTUs were then used to search the
Ribosomal Database Project’s set of quality-controlled, aligned, and annotated bacterial 16S rRNA sequences using SeqMatch36 in order to obtain nearest
neighbor matches with cultured representatives at the genus-species level. On the left are the phylum and family classifications of the OTUs and on the
right are the putative genus/species designation (numbers in parentheses indicate SeqMatch score [Sab]). The panel to the right of the heatmaps indicate
whether butyrate kinase (buk) or butyryl-CoA:acetate CoA-transferase (but) encoding genes have been detected in the genomes of the SeqMatch genus/
species assignments based on the buk and but entries in the RDP FunGene functional gene pipeline and repository64. A closed black circle indicates the
presence of a buk or but gene in that genome, whereas a closed gray circle indicates an alternate annotation (defined at the bottom of the figure). An open
circle indicates that no match was found in the RDP FunGene. Those listed in bold on the right are enriched in the PC+ FMT mice. c MEFs were treated
with of equal concentrations of filtered lysates from all four PC members (250 ng/mL) in the absence (striped) or presence of indicated amounts of
compounds for 12 h. MEF RNA was isolated and qPCR was performed to measure the effect of PC members on IRF3 expression in vitro (fold change
compared with the baseline of untreated MEF IRF3 relative expression [highlighted with the dotted line at y= 1] shown; three independent experiments;
n≥ 3 for all conditions; mean+ SD).
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For each gene, we subsequently used the empirical Bayes approach of Smyth40 to
calculate a moderated t statistic and P value. We corrected for multiple testing
using the false discovery rate (FDR) approach of Benjamini and Hochberg53. Gene
Ontology enrichment analysis were done using Gorilla54 using all expressed genes
(i.e., 13,312 genes) as a background set.
16S rRNA analysis. Microbial DNA was extracted from cecal luminal contents
and cecal tissues using Bacteremia DNA Isolation Kit (BiOstic, 12240-50), and the
16S rRNA analysis was performed at Argonne National Laboratories (Lemont, IL).
Samples were analyzed by 16S rRNA V4 iTAG amplicon sequencing analysis.
Paired end reads were quality trimmed and processed for OTU (operational
taxonomic unit) clustering using UPARSE pipeline55, set at 0.97% identity cutoff.
Taxonomic status was assigned to the high quality (<1% incorrect bases) candidate
OTUs using the “parallel_assign_taxonomy_rdp.py” script of QIIME software56.
Multiple sequence alignment and phylogenetic reconstruction was performed using
PyNast and FastTree56. OTU matrix was processed to remove OTUs containing
less than five reads in order to reduce the PCR and sequencing based bias; then the
OTU table was rarified to the minimum numbers of reads present in the smallest
library. We used the oligotyping pipeline57 to identify the sub-OTU level differ-
ences in the introduced pathogen strains of K. oxytoca ICU1-2, S. marcescens ICU1-
2, and E. faecalis ICU1-2. Full length 16S rRNA gene sequence was extracted from
genome sequences of K. oxytoca, S. marcescens, and E. faecalis genomes using
Blastn. Megablast (minimum identity cutoff= 100%) was used to confirm the
strain identification between full length 16S rRNA gene sequences and oligotype
representative sequences.
Sequencing of bacterial pathogen genomes. For isolation of DNA, strains of the
original stock consisting of K. oxytoca, S. marcescens, and E. faecalis were collected
from exponential phase during growth in liquid TSB. Sequence libraries were
generated using Nextera XT protocol according to manufacturer’s instructions
(Illumina). Libraries were sequenced by whole-genome shotgun sequencing using
the Illumina HiSeq system at Argonne National Laboratory (Lemont, IL).
Approximately 100-fold coverage of each genome was generated. Reference-guided
genome assembly was conducted using a combination of de novo assembly and
read alignment to the K. oxytoca CAV1374 (NZ_CP011636.1), S. marcescens
CAV1492 (NZ_CP011642.1), or E. faecalis V583 (NC_004668.1) genome. De novo
assembly was performed using the Spades version 3.5.058 for each species. Reads
were aligned to the appropriate species-specific reference genome using Bowtie2
version 2.2.559. Contigs from de novo assembly, greater than 1000 bp in length,
were placed onto the reference genome using BLAST version 2.2.3060, and merged
into longer scaffolds with reference-aligned sequence using custom Perl scripts.
The draft genome sequence of K. oxytoca ICU1-2b is 5,852,736 bp in length across
12 scaffolds, S. marcescens ICU1-2a is 5,115,171 bp in length across 20 scaffolds
and E. faecalis ICU1-2c is 2,929,980 bp in length across 14 scaffolds. Accession
numbers in NCBI are LQAM00000000 Enterococcus, LQAL00000000 Klebsiella,
and LQAK00000000 Serratia in the BioProject PRJNA307050.
Intraperitoneal (IP) sepsis mouse model. In order to determine if the rescue
effect of FMT functions at the level systemic infection, we directly injected mice
with the PC into the peritoneum (i.p.). In this IP model, mice were not subjected to
starvation, antibiotic treatment, or hepatectomy. The suspension was prepared
using the identical strains (S. marcescens, C. albicans, K. oxytoca, and E. faecalis)
and methods above. One milliliter of PC was injected intraperitoneally using a
1 mL insulin syringe (BD). The optimal and lethal dose of PC was determined by
preliminary experiments. FMT and AC-FMT were prepared as described above.
Each mouse received two doses of either FMT, AC-FMT immediately after i.p.
injection and 14 h later. Survival and health status were monitored and docu-
mented for 72 h using the clinical scoring system shown in Supplementary Table 2
(mice that survive until this point, regardless of treatment group return to full
health and survive indefinitely). All mice that were moribund were sacrificed and
considered to be a mortality.
Quantitative polymerase chain reaction (qPCR). RNA was isolated from cecum,
liver, and spleen as before and converted to cDNA using reverse transcriptase
(Promega) according to the manufacturer’s instructions. Expression analysis was
performed in duplicate via qPCR on a Roche LightCycler 480 using SYBR
Advantage qPCR Premix (Clontech).
Expression levels were quantified and normalized to housekeeping genes HPRT
(for qPCR on organs in both mouse models), GAPDH (for in vitro MEF
experiments), or ASL (for 16S relative expression). For Fig. 3b, Supplementary
Fig. 3a, and Fig. 4d, relative expression values were normalized to the mean of the
untreated controls for each organ and displayed as fold change to allow for display
on the same axis. For Fig. 3c, Supplementary Fig. 3b, c, and Fig. 4b, relative
expression values were normalized to untreated MEF baseline relative expression
for each gene (indicated with a dotted line at 1) and displayed as fold change. For
Supplementary Fig. 4a, the number of 16S copies was calculated using a purified
Ruminococcus productus DNA standard and normalized to the relative expression
of host ASL for each mouse assessed61. The qPCR primers shown in
Supplementary Table 4 were custom ordered from Integrated DNA Technologies.
MEF and PC co-culture. C57BL/6 primary MEFs were obtained from 12.5 to
14.5 days post coitus embryos and cultured in Dulbecco’s Modified Eagle’s Med-
ium (Gibco) supplemented with 10% fetal bovine serum (Gibco), and 1% non-
essential amino acids (Gibco). MEFs were plated at a density of 2.5 × 105/mL in 24-
well plates (Costar) overnight. Live PC members were prepared as before to an
OD600 of 0.2, and diluted (1/105 by volume) in MEF containing culture media. PC
lysates were prepared by taking live PC culture, bead beating with 0.1-mm diameter
glass beads (BioSpec) for 5 min and filtering using Millex-GV 0.22-µm filter
(Millipore). Plates were incubated at 37 °C, 5% CO2 for 1, 3, 6, and 14 h for live PC,
or 12 h for lysates in the presence of acetic acid (Fisher), butyric acid (Sigma),
propionic acid (Sigma), nicotinic acid (Sigma), or valproic acid sodium salt (Sigma)
at the indicated concentrations. After incubation, culture media was removed and
cells were harvested in Buffer RLT Plus (Qiagen) with 1% 2-Mercaptoethanol
(Sigma) and RNA extraction was performed using the RNeasy Plus Mini Kit
(Qiagen) according to the manufacturer’s instructions. All MEF experiments were
≥2 independent experiments, with at least two experimental replicates/experiment.
The mean fold change for each experiment was plotted and represented as bar
graphs.
Gas chromatography–mass spectrometry. SCFA were extracted from mouse
cecal contents using diethyl ether (Fisher Scientific), derivatized using N-tert-
Butyldimethylsilyl-N-methyltrifluoroacetamide with 1% tert-
Butyldimethylchlorosilane (Sigma) and run on an Agilent Single Quad GC–MS
(5977A Single Quad and 7890B GC). All values are normalized to fecal sample
mass. Raw spectral data were uploaded to the MassIVE repository (https://doi.org/
10.25345/C5JQ3V).
Statistical analysis. Statistical analysis was performed using GraphPad Prism
software. Unpaired t-test (two-tailed) was used when analyzing the differences
between two means, whereas one-way ANOVA/Tukey’s multiple comparisons
test was used when more than two means were compared. To determine
the statistical significance of quantitative culture analyses, we used nonpara-
metric tests because of the distribution of data: Mann–Whitney test (two-tailed)
was used to when two groups were compared, Kruskal–Wallis test/Dunn’s
multiple correction test was used for three groups. Log-rank (Mantel–Cox) test
was used to determine statistical significance between Kaplan–Meier survival
curves.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The datasets generated during and/or analyzed during the current study are available in
the Article, Supplementary Information files, or available from the corresponding author
on reasonable request. Microarray data was uploaded to the NCBI Gene Expression
Omnibus database, GEO accession number: GSE71530. Genome sequences of the ICU1-
2 pathogen community members were uploaded to NCBI in BioProject PRJNA307050.
Raw spectral data for measurement of SCFA by GC–MS were uploaded to the MassIVE
repository [https://doi.org/10.25345/C5JQ3V].
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